Investigation of Thermal Injury on Intestinal Permeability in Both Thermal Injury and Healthy Participants

PHASE1TerminatedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 29, 2018

Primary Completion Date

March 26, 2018

Study Completion Date

March 26, 2018

Conditions
Burns
Interventions
OTHER

Lactulose and Mannitol solution

Participants will receive 100 milliliter (mL) oral solution of Lactulose \[5 grams (g)\]/ Mannitol (2g), a non-investigational medicinal product, by oral route to measure intestinal permeability.

OTHER

Sucralose

Participants will receive 3 capsules of Sucralose (2g), a non-investigational medicinal product, by oral route to measure intestinal permeability.

Trial Locations (1)

B15 2TH

GSK Investigational Site, Birmingham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT03242434 - Investigation of Thermal Injury on Intestinal Permeability in Both Thermal Injury and Healthy Participants | Biotech Hunter | Biotech Hunter